Royal DSM In Negotiations To Acquire Adare Biome
Royal DSM (RDSMY.PK) has entered into exclusive negotiations with Adare Pharma Solutions in order to acquire Adare Biome, a pioneer in the development and manufacturing of postbiotics, for an enterprise value of 275 million euros.
Source: rttnews.com